Novo Nordisk is facing “unprecedented” price pressures, “intensifying competition” and patents expiring.#Wegovy #maker #warns #039painful039 #price #cuts #shares #plunge
Novo Nordisk is facing “unprecedented” price pressures, “intensifying competition” and patents expiring.#Wegovy #maker #warns #039painful039 #price #cuts #shares #plunge